Because of the limitations of this type of study, the research cant prove that hormone therapy directly caused the additional weight loss but it supports the idea that estrogen may influence how some women respond to GLP-1s
Bioorg Chem 106:104492 Pan Q, Lin S, Li Y, Liu L, Li X, Gao X, Yan J, Gu B, Chen X, Li W, Tang X, Chen C, Guo L (2021) A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis
Most long-acting injectable GLP-1 receptor agonists can be administered with or without food there is no requirement to take them on an empty stomach
The phentermine component can cause insomnia, affecting 11% of patients, and may increase heart rate and blood pressure